|
WO1991004753A1
(en)
|
1989-10-02 |
1991-04-18 |
Cetus Corporation |
Conjugates of antisense oligonucleotides and therapeutic uses thereof
|
|
WO1991014452A1
(en)
|
1990-03-27 |
1991-10-03 |
The Salk Institute For Biological Studies |
Method for inhibiting cell growth and compositions useful therefor
|
|
US5648469A
(en)
|
1992-04-20 |
1997-07-15 |
The Salk Institute For Biological Studies |
Monoclonal antibodies reactive with transferrin receptor cytoplasmic domain
|
|
CA2561830C
(en)
|
2004-03-31 |
2013-05-21 |
Adnagen Ag |
Monoclonal antibodies with specificity for fetal erythroid cells
|
|
WO2005094364A2
(en)
|
2004-03-31 |
2005-10-13 |
Chimeric Technologies, Inc. |
Iga antibody protein as a cytotoxic drug
|
|
PT1740616E
(pt)
|
2004-04-30 |
2012-03-23 |
Inst Nat Sante Rech Med |
Anticorpo anti-rtf
|
|
JP4824025B2
(ja)
*
|
2004-06-07 |
2011-11-24 |
マクロジェニックス ウエスト，インコーポレイテッド |
トランスフェリンレセプター抗体
|
|
AU2005287406B2
(en)
|
2004-07-26 |
2011-08-18 |
Biogen Ma Inc. |
Anti-CD154 antibodies
|
|
CA2600929A1
(en)
|
2005-03-04 |
2006-09-14 |
Biogen Idec Ma Inc. |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
|
|
US7736647B2
(en)
|
2005-06-15 |
2010-06-15 |
Monoclonal Antibodies Therapeutics |
Anti-CD71 monoclonal antibodies and uses thereof for treating malignant tumor cells
|
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
FR2953841B1
(fr)
|
2009-12-16 |
2011-12-30 |
Centre Nat Rech Scient |
Anticorps diriges contre le recepteur de la transferrine et leurs utilisations pour l'immunotherapie des tumeurs qui dependent du fer
|
|
FR2959416B1
(fr)
|
2010-05-03 |
2012-06-22 |
Monoclonal Antibodies Therapeutics Mat Biopharma |
Utilisation d'anticorps anti-cd71 pour la preparation d'un medicament
|
|
CA2818173C
(en)
|
2010-11-30 |
2022-05-03 |
Genentech, Inc. |
Low affinity blood brain barrier receptor antibodies and uses therefor
|
|
CA2835603A1
(en)
|
2011-05-09 |
2012-11-15 |
Perseus Proteomics Inc. |
Antibody capable of specifically recognizing transferrin receptor
|
|
TWI450727B
(zh)
|
2011-12-29 |
2014-09-01 |
財團法人工業技術研究院 |
抗人類輸鐵蛋白受體的單域抗體與其應用
|
|
AU2013203422A1
(en)
|
2012-01-06 |
2013-07-18 |
Bioalliance C.V. |
Anti-transferrin receptor antibodies and methods using same
|
|
HUE045144T2
(hu)
|
2012-08-29 |
2019-12-30 |
Hoffmann La Roche |
Véragygát-shuttle
|
|
CA2893794C
(en)
|
2012-11-08 |
2021-11-09 |
University Of Miyazaki |
Antibody capable of specifically recognizing transferrin receptor
|
|
EP2971047A4
(en)
|
2013-03-15 |
2016-11-30 |
Alper Biotech Llc |
MONOCLONAL ANTIBODIES TO TRANSFERRIN AND TRANSFERRIN RECEPTOR ANTIGEN AND USES THEREOF
|
|
EP3594240B1
(en)
|
2013-05-20 |
2023-12-06 |
F. Hoffmann-La Roche AG |
Anti-transferrin receptor antibodies and methods of use
|
|
US9499628B2
(en)
|
2013-06-14 |
2016-11-22 |
Children's Hospital Medical Center |
Method of boosting the immune response in neonates
|
|
EP3088518A4
(en)
|
2013-12-25 |
2017-09-20 |
JCR Pharmaceuticals Co., Ltd. |
Novel anti-transferrin receptor antibody that passes through blood-brain barrier
|
|
CA2932547C
(en)
|
2014-01-06 |
2023-05-23 |
F. Hoffmann-La Roche Ag |
Monovalent blood brain barrier shuttle modules
|
|
US10508151B2
(en)
*
|
2014-11-19 |
2019-12-17 |
Genentech, Inc. |
Anti-transferrin receptor antibodies and methods of use
|
|
BR112017023862A2
(pt)
*
|
2015-05-04 |
2018-07-17 |
Cytomx Therapeutics Inc |
anticorpos anti-cd71, anticorpos anti-cd71 ativáveis, e métodos de uso destes
|
|
EA039366B1
(ru)
|
2015-06-24 |
2022-01-19 |
Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. |
Антитело к рецептору трансферрина человека, проникающее через гематоэнцефалический барьер
|
|
HUE057952T2
(hu)
|
2015-06-24 |
2022-06-28 |
Hoffmann La Roche |
Anti-transzferrin receptor antitestek testreszabott affinitással
|
|
RU2737637C2
(ru)
|
2015-07-22 |
2020-12-01 |
Инатерис |
Антитела против tfr и их применение при лечении пролиферативных и воспалительных расстройств
|
|
TWI873952B
(zh)
|
2015-10-02 |
2025-02-21 |
瑞士商赫孚孟拉羅股份公司 |
雙特異性抗‐人類cd20/人類轉鐵蛋白受體抗體及使用方法
|
|
JP2019513371A
(ja)
|
2016-04-01 |
2019-05-30 |
アビディティー バイオサイエンシーズ エルエルシー |
核酸ポリペプチド組成物とその使用
|
|
DK3473270T5
(da)
|
2016-06-20 |
2024-09-09 |
Genahead Bio Inc |
Konjugat af antistof-lægemiddel
|
|
WO2018081720A1
(en)
|
2016-10-29 |
2018-05-03 |
Rhode Island Hospital |
Glycosylated transferrin receptor 1 tumor antigen
|
|
KR102497564B1
(ko)
|
2016-12-26 |
2023-02-07 |
제이씨알 파마 가부시키가이샤 |
혈액뇌관문을 통과하는 신규한 항인간 트랜스페린 수용체 항체
|
|
CA3053381A1
(en)
|
2017-02-17 |
2018-08-23 |
Denali Therapeutics Inc. |
Engineered polypeptides
|
|
US10457717B2
(en)
|
2017-02-17 |
2019-10-29 |
Denali Therapeutics Inc. |
Engineered polypeptides
|
|
EP3665194A4
(en)
|
2017-08-10 |
2021-07-07 |
Denali Therapeutics Inc. |
AFFINITY BASED METHODS OF USING TRANSFERRIN RECEPTOR BINDING PROTEINS
|
|
AU2018378812B2
(en)
|
2017-12-06 |
2025-05-22 |
Avidity Biosciences, Inc. |
Compositions and methods of treating muscle atrophy and myotonic dystrophy
|
|
IL276327B2
(en)
|
2018-02-05 |
2024-05-01 |
Japan Chem Res |
Method for delivering drug to muscle
|
|
US20210317226A1
(en)
|
2018-08-02 |
2021-10-14 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating pompe disease
|
|
WO2020028836A1
(en)
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes and uses thereof in treating muscle atrophy
|
|
IL280536B2
(en)
|
2018-08-02 |
2024-12-01 |
Dyne Therapeutics Inc |
Complexes targeting transferrin receptor and uses thereof
|
|
SG11202100928QA
(en)
|
2018-08-02 |
2021-02-25 |
Dyne Therapeutics Inc |
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
|
|
WO2020028842A1
(en)
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating hypertrophic cardiomyopathy
|
|
CA3108282A1
(en)
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
KR20210086601A
(ko)
|
2018-08-02 |
2021-07-08 |
다인 세라퓨틱스, 인크. |
근육 표적화 복합체 및 프리드라이히 운동실조를 치료하기 위한 그의 용도
|
|
AU2019314538B2
(en)
|
2018-08-02 |
2025-03-13 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
EP3829645A4
(en)
|
2018-08-02 |
2022-05-18 |
Dyne Therapeutics, Inc. |
MUSCLE TARGETING COMPLEXES AND THEIR USES FOR THE TREATMENT OF PROGRESSIVE FIBRODYSPLASIA OSSIFIANS
|
|
EP3830130A4
(en)
|
2018-08-02 |
2022-05-18 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating centronuclear myopathy
|
|
WO2020104479A1
(en)
|
2018-11-20 |
2020-05-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for treating cancers and resistant cancers with anti transferrin receptor 1 antibodies
|
|
US20240148891A1
(en)
|
2019-10-18 |
2024-05-09 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
AU2021206234A1
(en)
|
2020-01-10 |
2022-09-01 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
CA3163608A1
(en)
|
2020-01-10 |
2021-07-15 |
Romesh R. Subramanian |
Muscle-targeting complexes and uses thereof
|
|
US20230103793A1
(en)
*
|
2020-01-31 |
2023-04-06 |
Dyne Therapeutics, Inc. |
Anti-transferrin receptor (tfr) antibody and uses thereof
|
|
KR20230041760A
(ko)
|
2020-07-23 |
2023-03-24 |
다인 세라퓨틱스, 인크. |
항-트랜스페린 수용체 (tfr) 항체 및 그의 용도
|
|
CA3202832A1
(en)
|
2020-12-31 |
2022-07-07 |
Romesh R. Subramanian |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|